Alexion Pharm Inc (ALXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,228,900 | 727,500 | 511,800 | 584,400 | 550,000 |
| Marketable Securities | 306,200 | 449,500 | 1,079,100 | 889,700 | 979,000 |
| Receivables | 910,200 | 853,700 | 776,700 | 726,500 | 705,000 |
| Inventories | 432,700 | 463,200 | 456,500 | 460,400 | 441,000 |
| TOTAL | $3,248,400 | $2,836,100 | $3,152,000 | $2,953,900 | $2,882,000 |
| Non-Current Assets | |||||
| PPE Net | 1,443,400 | 1,422,600 | 1,379,300 | 1,325,400 | 1,354,000 |
| Intangibles | 8,751,000 | 8,831,200 | 8,911,500 | 8,991,800 | 9,069,000 |
| Other Non-Current Assets | 400,800 | 400,500 | 387,400 | 312,200 | 338,000 |
| TOTAL | $10,595,200 | $10,654,300 | $10,678,200 | $10,629,400 | $10,761,000 |
| Total Assets | $13,843,600 | $13,490,400 | $13,830,200 | $13,583,300 | $13,643,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 61,200 | 28,500 | 167,500 | 167,400 | 167,000 |
| Accounts payable and accrued liabilities | 52,200 | 58,800 | 57,100 | 710,200 | 35,000 |
| Accrued Expenses | 539,800 | 605,200 | 582,800 | N/A | 703,000 |
| Other current liabilities | 124,200 | 101,900 | 134,600 | 74,900 | 49,000 |
| TOTAL | $1,027,400 | $1,044,400 | $942,000 | $952,500 | $972,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,533,300 | 2,564,900 | 2,678,800 | 2,720,700 | 2,763,000 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 18,000 |
| aiOther Non-Current Liabilities | 309,200 | 288,300 | 303,800 | 309,100 | 278,000 |
| TOTAL | $3,646,500 | $3,678,600 | $3,775,500 | $3,737,700 | $3,727,000 |
| Total Liabilities | $4,673,900 | $4,723,000 | $4,717,500 | $4,690,200 | $4,699,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 223,097 | 222,859 | 222,501 | 221,681 | 223,410 |
| Retained earnings | 2,370,900 | 2,040,000 | 2,497,400 | 2,242,100 | 2,212,000 |
| Other shareholders' equity | 7,000 | -2,800 | -45,600 | -34,300 | -37,000 |
| TOTAL | $9,169,700 | $8,767,400 | $9,112,700 | $8,893,100 | $8,944,000 |
| Total Liabilities And Equity | $13,843,600 | $13,490,400 | $13,830,200 | $13,583,300 | $13,643,000 |